Lars Frings

Lars Frings

Auto-generated profile, based on publicly available information

Lars Frings

Department of Nuclear Medicine, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Brain
Verified
Journal Article
Closed access
JHJonas A. Hosp
Jonas A. Hosp
ADAndrea Dressing
Andrea Dressing
GBGanna Blazhenets
Ganna Blazhenets
TBTobias Bormann
Tobias Bormann
ARAlexander Rau
Alexander Rau
PMPhilipp T Meyer
Philipp T Meyer
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, neurological symptoms increasingly moved into the focus of interest. In this prospective cohort study, we assessed neurological and cognitive symptoms in hospitalized coronavirus disease-19 (COVID-19) patients and aimed to determine their neuronal correlates. Patients with reverse transcription-PCR-confirmed COVID-19 infection who required inpatient treatment primarily because of non-neurological complications were screened between 20 April 2020 and 12 May 2020. Patients (age > 18 years) were included in our cohort when presenting with at least one new neurological symptom (defined as impaired gustation and/or olfaction, performance < 26 points on a Montreal Cognitive Assessment and/or pathological findings on clinical neurological examination). Patients with ≥2 new symptoms were eligible for further diagnostics using comprehensive neuropsychological tests, cerebral MRI and 18fluorodeoxyglucose (FDG) PET as soon as infectivity was no longer present. Exclusion criteria were: premorbid diagnosis of cognitive impairment, neurodegenerative diseases or intensive care unit treatment. Of 41 COVID-19 inpatients screened, 29 patients (65.2 ± 14.4 years; 38% female) in the subacute stage of disease were included in the register. Most frequently, gustation and olfaction were disturbed in 29/29 and 25/29 patients, respectively. Montreal Cognitive Assessment performance was impaired in 18/26 patients (mean score 21.8/30) with emphasis on frontoparietal cognitive functions. This was confirmed by detailed neuropsychological testing in 15 patients. 18FDG PET revealed pathological results in 10/15 patients with predominant frontoparietal hypometabolism. This pattern was confirmed by comparison with a control sample using voxel-wise principal components analysis, which showed a high correlation (R2 = 0.62) with the Montreal Cognitive Assessment performance. Post-mortem examination of one patient revealed white matter microglia activation but no signs of neuroinflammation. Neocortical dysfunction accompanied by cognitive decline was detected in a relevant fraction of patients with subacute COVID-19 initially requiring inpatient treatment. This is of major rehabilitative and socioeconomic relevance.

1 July 2016 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
SHSabine Hellwig
Sabine Hellwig
SBSimone Brioschi
Simone Brioschi
SDSandra Dieni
Sandra Dieni
LFLars Frings
Lars Frings
AMAnnette Masuch
Annette Masuch
KBKnut Biber
Knut Biber

14 September 2017 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
PMPhilipp T. Meyer
Philipp T. Meyer
LFLars Frings
Lars Frings
GRGerta Rucker
Gerta Rucker
SHSabine Hellwig
Sabine Hellwig
Accurate differential diagnosis of parkinsonism is of paramount therapeutic and prognostic importance. In addition, with the development of invasive therapies and novel disease-specific therapies, strategies for patient enrichment in trial populations are of growing importance. Imaging disease-specific patterns of regional glucose metabolism with PET and 18F-FDG allows for a highly accurate distinction between Parkinson disease (PD) and atypical parkinsonian syndromes, including multiple-system atrophy, progressive supranuclear palsy, and corticobasal degeneration. On the basis of a preliminary metaanalysis of currently available studies with inclusion of multiple disease groups, we estimated that the diagnostic sensitivity and specificity for visual PET readings supported by voxel-based statistical analyses for diagnosis of atypical parkinsonian syndromes are 91.4% and 90.6%, respectively. The diagnostic specificity of 18F-FDG PET for diagnosing multiple-system atrophy, progressive supranuclear palsy, and corticobasal degeneration was consistently shown to be high (>90%), whereas sensitivity was more variable (>75%). It is increasingly acknowledged that cognitive impairment represents a major challenge in PD, with mild cognitive impairment being a prodromal stage of PD with dementia (PDD). In line with clinical and neuropsychologic studies, recent PET studies demonstrated that posterior cortical dysfunction in nondemented PD patients precedes cognitive decline and the development of PDD by several years. Taken together, the current literature underscores the utility of 18F-FDG PET for diagnostic evaluation of parkinsonism and the promising role of 18F-FDG PET for assessment and risk stratification of cognitive impairment in PD.

26 September 2018 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
DBDavid Bergeron
David Bergeron
MGMaria L. Gorno‐Tempini
Maria L. Gorno‐Tempini
GRGil D. Rabinovici
Gil D. Rabinovici
MSMiguel A. Santos‐Santos
Miguel A. Santos‐Santos
WSWilliam Seeley
William Seeley
RORik Ossenkoppele
Rik Ossenkoppele

1 May 2007 in Epilepsy & Behavior
Verified
Journal Article
Closed access
BGBettina Gomer
Bettina Gomer
KWKathrin Wagner
Kathrin Wagner
LFLars Frings
Lars Frings
JSJosef Saar
Josef Saar
ACAstrid Carius
Astrid Carius
ASAndreas Schulze-Bonhage
Andreas Schulze-Bonhage

13 August 2015 in Brain
Verified
Journal Article
Closed access
PDF file
LFLars Frings
Lars Frings
SHSabine Hellwig
Sabine Hellwig
TSTimo S. Spehl
Timo S. Spehl
TBTobias Bormann
Tobias Bormann
RBRalph Buchert
Ralph Buchert
PMPhilipp T. Meyer
Philipp T. Meyer
Clinical Alzheimer’s disease affects both cerebral hemispheres to a similar degree in clinically typical cases. However, in atypical variants like logopenic progressive aphasia, neurodegeneration often presents asymmetrically. Yet, no in vivo imaging study has investigated whether lateralized neurodegeneration corresponds to lateralized amyloid-β burden. Therefore, using combined 11C-Pittsburgh compound B and 18F-fluorodeoxyglucose positron emission tomography, we explored whether asymmetric amyloid-β deposition in Alzheimer’s disease is associated with asymmetric hypometabolism and clinical symptoms. From our database of patients who underwent positron emission tomography with both 11C-Pittsburgh compound B and 18F-fluorodeoxyglucose ( n = 132), we included all amyloid-positive patients with prodromal or mild-to-moderate Alzheimer’s disease ( n = 69). The relationship between 11C-Pittsburgh compound B binding potential and 18F-fluorodeoxyglucose uptake was assessed in atlas-based regions of interest covering the entire cerebral cortex. Lateralizations of amyloid-β and hypometabolism were tested for associations with each other and with type and severity of cognitive symptoms. Positive correlations between asymmetries of Pittsburgh compound B binding potential and hypometabolism were detected in 6 of 25 regions (angular gyrus, middle frontal gyrus, middle occipital gyrus, superior parietal gyrus, inferior and middle temporal gyrus), i.e. hypometabolism was more pronounced on the side of greater amyloid-β deposition (range: r = 0.41 to 0.53, all P < 0.001). Stronger leftward asymmetry of amyloid-β deposition was associated with more severe language impairment ( P < 0.05), and stronger rightward asymmetry with more severe visuospatial impairment (at trend level, P = 0.073). Similarly, patients with predominance of language deficits showed more left-lateralized amyloid-β burden and hypometabolism than patients with predominant visuospatial impairment and vice versa in several cortical regions. Associations between amyloid-β deposition and hypometabolism or cognitive impairment were predominantly observed in brain regions with high amyloid-β load. The relationship between asymmetries of amyloid-β deposition and hypometabolism in cortical regions with high amyloid-β load is in line with the detrimental effect of amyloid-β burden on neuronal function. Asymmetries were also concordant with lateralized cognitive symptoms, indicating their clinical relevance. * Abbreviations : AI : asymmetry index BPND : non-displaceable binding potential MMSE : Mini-Mental State Examination PiB : Pittsburgh compound B